MINNEAPOLIS, Sept. 13, 2017 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical” or the “Company”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the pricing of a previously announced underwritten registered offering by certain of its stockholders of 3,300,000 shares of Tactile Medical common stock at a price to the public of $33.00 per share. In connection with the offering, the selling stockholders have granted the underwriters an option to purchase up to an additional 495,000 shares. Tactile Medical will not receive any proceeds from the offering. The offering is expected to close on or about September 15, 2017, subject to satisfactory completion of customary closing conditions.
Top Finance
Search
New Posts
Gold Price Recovers Amid Uncertain US Economic Outlook
USD/CAD Price Analysis: Consolidates Around 1.3650 Ahead Of Fed’s Preferred Inflation Gauge
USDJPY Charges Higher: Uptrend Confirmed Or Bullish Momentum Extended?
Chevron’s Mixed Q1: $2.93 Adj. EPS, $48.72 B In Revenue
Eurozone Bank Lending Continues To Cautiously Recover
Leave A Comment